Duality Bio IPO Lockup - US$2.7bn Lockup Release, with Lots of CCASS Movement

372 Views14 Oct 2025 09:48

Duality Biotherapeutics (9606 HK)' s raised around US$200m in its Hong Kong listing in April 2025. The lockup on its cornerstone and pre-IPO investors is set to expire today.

What is covered in the Full Insight:

IPO Recap
Lockup Dynamics
Recent Updates
Development Pipeline
Concluding Thoughts

Sumeet Singh

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 4-minute read)

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream